According to a 2004 Rand Corporation report, depression results in more absenteeism than almost any other physical disorder and costs employers more than US$51 billion per year in absenteeism and lost productivity.
With the next few weeks, the FDA is expected to issue its final approval of vagus nerve stimulation as a treatment for chronic or recurrent depression. The approval of vagus nerve stimulation will be the first ever FDA approved long-term treatment option for the four million desperate Americans( and their families) who have not had an adequate response to traditional anti-depressants.
When approved, this treatment will be considered the one of major breakthroughs in medical device history. The benefits of this therapy include:
Vagus nerve stimulation is more effective than anti-depressants
VNS does not have the side effects of antidepressants
Compliance is guaranteed. Once the device is activated, there's no further action required
Efficacy improves over time ("No Prozac poop out")
Quality-of-life benefits improve over time
No drug interactions
No cognitive impairment (i.e. memory loss)
Stimulation to the left vagus nerve has been proven to favorably modulate those ares of the brain that are responsible for mood and depression. The procedure is unrelated to brain surgery or electroconvulsive therapy. The stimulator is implanted in the patient's upper left chest, just below the arm pit. A lead wire is then tunneled underneath the skin and coiled around the left vagus nerve in the neck. For cosmectic reasons, the incision is at the lowest fold of the patient's neck. The scar heals very quickly and is barely noticeable as it is difficult to diffentiate between the fold and the healed scar.
Learn more how this therapy can bring genuine happiness and joy to your life at http://www.vagusnervestimulator.com/ There is a free newsletter to keep you up-to-date on the latest developments. Also available on the site is the book
Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression. Do yourself a favor and become fully educated about this remarkable device. It could change your life.
Charles Donovan was a patient in the FDA investigational trial of vagus nerve stimulation as a treatment for chronic or recurrent treatment-resistant depression. He was implanted with the vagus nerve stimulator in April of 2001. He chronicles his journey from the grips of depression thanks to vagus nerve stimulation therapy in his book:
Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression
The book will be exhibited at the American Psychiatric Association's Annual Meeting, May 21st-May 26th in Atlanta, GA. This is the largest gathering of psychiatrists in the world( 25,000 attendees).